Amorepacific Corporation

Yonsei University

Korea Advanced Institute of Science and Technology

Snu Rdb Foundation

Si Young Cho

Dae Bang Seo

Sang Jun Lee

Wan Gi Kim

Chan Woong Park

Hyun Woo Jeong

Juewon Kim

Hyungsu Kim

Su Kyung Kim

Yong-Deog Hong

Wonseok Park

Byung Gyu Kim

Yong Deog Hong

Miyoung Park

Ji Hae Lee

Min Jeong Song

Jin Sung Kim

Jeong-kee Kim

Joonho Choi

Jaewon You

Pil Joon Park

Eui Seok Shin

Il Sung Bae

Hyun Jung Shin

Yeon Su Jeong

Ayoung Kim

Hyeon Ju Yeo

Minsik Choi

Hee Young Jeon

Wanki Kim

Eunmi Kim

Il Hong Bae

Kwang Hyun Cho

Soo Beom Lee

Dae-Bang Seo

A Young Kim

Byung-Young Kang

Ji Hyun Jeong

Ji Woong Ahn

Suk Jin Ko

Seung Soo Chung

Mihee Ji

Insup Kil

Jong Hee Sohn

Euidong Son

Hyung Su Kim

Yongwoo Jang

Min Ho Tak

Hawon Cho

Young Duk Yang

Jae Yeon Koo

Su Gyun An

Jun Soo Kang

Uhtaek Oh

Myeong Hoon No 101-902 Byeoksan Ap Yeom

Ih-Seop No 102-1104 Dongbo Apartment Chang

Tae Ryong No 932-1303 Taeyeong Apartment Lee

The disclosure relates to the method for alleviating skin irritation or inhibiting sebum production, which includes administering a composition including a compound represented by Chemical Formula 1, a salt thereof, a stereoisomer thereof, a hydrate thereof, or a solvate thereof as an active ingredient to a subject in need of alleviating skin irritation or inhibiting sebum production, and specifically the composition can alleviate the irritation of the skin stimulated by ultraviolet rays, and more specifically, the composition can alleviate the skin irritation by reducing inflammatory factors in the cells of the skin stimulated by simultaneous stimulation of UVA and UVB ultraviolet rays, and in addition, specifically, it is possible to suppress the sebum production by inhibiting intracellular lipid synthesis with the composition, and more specifically, the sebum production of the skin can be suppressed by reducing the expression level of the factors related to intracellular lipid synthesis with the composition.

Composition for suppressing skin irritation or inhibiting sebum secretion

The present disclosure relates to a composition for reducing body fat, which contains a green tea extract containing 4 wt % or more of gallocatechin gallate based on the total weight of the extract as an active ingredient, and a method for preparing the same. The composition according to the present disclosure provides a superior effect of reducing body fat as the green tea extract containing gallocatechin gallate is contained as an active ingredient. Accordingly, it can provide substances effective for treating obesity through various researches.

Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof

Disclosed is to provide a composition for skin-whitening or preventing or improving skin wrinkles, comprising a green tea extract which has modified amounts of ingredients. More specifically, the extract and composition according to one aspect of the present disclosure are derived from natural plants that cause less irritation to the skin and are eco-friendly, thus they are safe, and thereby the extract and composition can exhibit excellent effects of effectively inhibiting melanin production and tyrosinase activity and preventing or improving skin whitening, and can exhibit excellent effects of effectively inhibiting the expression of MMP-1 and preventing or improving skin wrinkles.

Composition for skin-whitening or preventing or improving skin wrinkles comprising green tea extract which has modified amounts of ingredients

A composition for inhibiting lipofuscin accumulation or removing lipofuscin is disclosed. Asp. strain, a lysate of thesp. strain, a culture of thesp. strain, or an extract of the lysate or culture is included in the composition. The composition provides an anti-aging effect by inhibiting lipofuscin accumulation or removing lipofuscin. The composition also provides an effect of preventing, ameliorating or treating the diseases caused by the lipofuscin accumulation, such as skin hyperpigmentation, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, myocardial infarction and age-related macular degeneration.

Composition for inhibiting lipofuscin accumulation or removing lipofuscin

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (&#x2212;)-gallocatechin gallate (GCG) and (&#x2212;)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.

Method for preventing, alleviating, improving, or treating the female hormone controlling disorder syndrome or symptoms comprising a step of administering green tea extract which has modified amounts of ingredients

Disclosed is to provide a composition which is derived from a natural product and exhibits an excellent effect of protecting cells from oxidative stress and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural product, thus are safe. It can prevent, ameliorate and treat oxidative stress and neuron damage. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.

Composition for protecting cell from oxidative stress comprising green tea extract which has modified amounts of ingredients

The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

SIRT 1 activator including syringaresinol

The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.

Post fermented tea-derived kaempferol-based compound

Disclosed is to provide a composition derived from a natural material and which has an excellent effect of enhancing cognitive function and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural material and thus are safe. It can prevent, ameliorate and treat cognitive decline. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.

Composition for enhancing cognitive function comprising green tea extract which has modified amounts of ingredients

The present specification relates to a novel quercetin-based compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.

Quercetin-based compound

Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-&#x3b4; (PPAR-&#x3b4;), which containsextracts orextracts as active ingredients. The composition is effective in strengthening muscles, improving endurance and memory, and preventing and alleviating the symptoms of dementia or Parkinson's disease.

Composition for promoting the activity of peroxisome proliferator-activated receptor-delta

Growing community of inventors

Yongin-si, South Korea

Si Young Cho